ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,818Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 807

$802K Total Retail Price of All Prescriptions

Rank: 18 out of 807

354 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 354 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 15,823 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
OMEPRAZOLE 823 762 1 4
LISINOPRIL 636 589 2 2
SIMVASTATIN 629 571 3 1
HYDROCHLOROTHIAZIDE 622 587 4 9
PRAVASTATIN SODIUM 537 519 5 21
ATENOLOL 517 478 6 7
AMLODIPINE BESYLATE 509 481 7 5
METFORMIN HCL 482 457 8 12
HYDRALAZINE HCL 451 426 9 62
METOPROLOL TARTRATE 428 414 10 8
ZOLPIDEM TARTRATE 417 384 11 23
FUROSEMIDE 370 367 12 6
LEVOTHYROXINE SODIUM 353 338 13 3
ATORVASTATIN CALCIUM 353 342 13 11
TRAMADOL HCL 341 313 15 19
GABAPENTIN 328 298 16 16
ISOSORBIDE MONONITRATE ER 313 313 17 36
MECLIZINE HCL 237 229 18 194
GLIPIZIDE 212 191 19 58
LOSARTAN POTASSIUM 198 191 20 14
ACTOS 192 191 21 151
ALENDRONATE SODIUM 186 184 22 20
JANUVIA 183 169 23 79
COLCRYS 176 163 24 169
IBUPROFEN 166 156 25 97
PROAIR HFA 163 157 26 43
LIPITOR 145 145 27 100
NITROSTAT 145 144 27 104
ALLOPURINOL 142 134 29 26
METOPROLOL SUCCINATE 142 136 29 13
CITALOPRAM HBR 141 131 31 17
LOSARTAN-HYDROCHLOROTHIAZIDE 139 133 32 55
DICLOFENAC SODIUM 137 126 33 231
POTASSIUM CHLORIDE 137 119 33 18
PREDNISONE 136 129 35 24
RANITIDINE HCL 135 135 36 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 134 134 37 28
TAMSULOSIN HCL 129 129 38 27
WARFARIN SODIUM 126 108 39 10
LANSOPRAZOLE 121 119 40 103
AMLODIPINE BESYLATE-BENAZEPRIL 118 118 41 117
PLAVIX 116 116 42 60
PRANDIN 109 105 43 255
PANTOPRAZOLE SODIUM 105 105 44 44
GLIPIZIDE XL 102 102 45 94
NAPROXEN 100 86 46 112
GLIPIZIDE ER 98 91 47 67
FLUOCINONIDE 97 92 48 265
SULINDAC 97 75 48 175
ZETIA 96 71 50 59
LIDODERM 89 87 51 96
DOXAZOSIN MESYLATE 82 82 52 70
NASONEX 79 79 53 236
LANTUS 76 64 54 45
ADVAIR DISKUS 75 69 55 33
ALFUZOSIN HCL 74 74 56 206
NEXIUM 72 68 57 68
DONEPEZIL HCL 71 71 58 31
CLONIDINE 70 70 59 290
POLYETHYLENE GLYCOL 3350 65 65 60 40
AMMONIUM LACTATE 64 60 61 226
GEMFIBROZIL 60 48 62 74
DIOVAN 60 49 62 46
LANTUS SOLOSTAR 59 58 64 42
SINGLE USE SWAB 57 50 65 234
CLOPIDOGREL 57 57 65 47
INDOMETHACIN 53 49 R 67 323
AMBIEN 52 52 10 68 328
FLUTICASONE PROPIONATE 52 45 68 30
MIRTAZAPINE 50 50 70 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.